Cost-Utility of Bilateral Versus Unilateral Cochlear Implantation in Adults: A Randomized Controlled Trial

Autor: Wendy J. Huinck, Yvette E. Smulders, Inge Stegeman, Wilko Grolman, Albert B. Rinia, Rolien Free, Gijsbert A. van Zanten, Vedat Topsakal, Emmanuel A. M. Mylanus, Robert J. Stokroos, Bert Maat, Alice van Zon, Johan H. M. Frijns
Přispěvatelé: Surgical clinical sciences, Ear, nose & throat, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, MUMC+: MA Keel Neus Oorheelkunde (9), KNO, Perceptual and Cognitive Neuroscience (PCN)
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
Pediatrics
Cost effectiveness
medicine.medical_treatment
Cost-Benefit Analysis
health status
Deafness
Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]
Functional Laterality
law.invention
surgery
Indirect costs
0302 clinical medicine
Randomized controlled trial
law
Cochlear implant
Young adult
030223 otorhinolaryngology
Non-U.S. Gov't
PERSPECTIVE
Cost-utility
Research Support
Non-U.S. Gov't

Age Factors
Middle Aged
Cochlear Implantation
Sensory Systems
STATE
Multicenter Study
Treatment Outcome
Randomized Controlled Trial
young adult
Female
Quality-Adjusted Life Years
medicine.symptom
Adult
medicine.medical_specialty
Adolescent
Hearing loss
Research Support
03 medical and health sciences
Deafness/economics
medicine
Journal Article
health care costs
Humans
Comparative Study
Cochlear Implants/economics
Aged
Bilateral cochlear implantation
business.industry
Cochlear Implantation/economics
Surgery
Quality-adjusted life year
LIFE
Cochlear Implants
Otorhinolaryngology
life expectancy
Cost-effectiveness
Neurology (clinical)
Implant
business
030217 neurology & neurosurgery
Zdroj: Otology and Neurotology, 37(1), 38-45
Otology & Neurotology, 37, 38-45
Otology & Neurotology, 37(1), 38. Lippincott Williams and Wilkins
Otology & Neurotology, 37, 1, pp. 38-45
Otology & Neurotology, 37(1), 38-45. LIPPINCOTT WILLIAMS & WILKINS
ISSN: 1531-7129
Popis: Item does not contain fulltext OBJECTIVE: To study the cost-utility of simultaneous bilateral cochlear implantation (CI) versus unilateral CI. STUDY DESIGN: Randomized controlled trial (RCT). SETTING: Five tertiary referral centers. PATIENTS: Thirty-eight postlingually deafened adults eligible for cochlear implantation. INTERVENTIONS: A cost-utility analysis was performed from a health insurance perspective. MAIN OUTCOME MEASURES: Utility was assessed using the HUI3, TTO, VAS on hearing, VAS on general health and EQ-5D. We modeled the incremental cost per quality-adjusted life year (QALY) of unilateral versus bilateral CI over periods of 2, 5, 10, 25 years, and actual life-expectancy. RESULTS: Direct costs for unilateral and bilateral CI were euro43,883 +/- euro11,513(SD) and euro87,765 +/- euro23,027(SD) respectively. Annual costs from the second year onward were euro3,435 +/- euro1,085(SD) and euro6,871 +/- euro2,169(SD), respectively. A cost-utility analysis revealed that a second implant became cost-effective after a 5- to 10-year period, based on the HUI3, TTO, and VAS on hearing. CONCLUSION: This is the first study that describes a cost-utility analysis to compare unilateral with simultaneous bilateral CI in postlingually deafened adults, using a multicenter RCT. Compared with accepted societal willingness-to-pay thresholds, simultaneous bilateral CI is a cost-effective treatment for patients with a life expectancy of 5-10 years or longer.
Databáze: OpenAIRE